Nasdaq · REGN
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals (REGN) is listed on Nasdaq, in the Health Care sector (Biotechnology). It is in the S&P 500 and the Nasdaq-100. This page shows a TradingView chart for REGN and the company's recent annual and quarterly reports from the SEC EDGAR database. It does not include a price quote.
SEC filings
Industry code, fiscal year and filing dates come from the SEC’s EDGAR submissions feed for CIK 872589. The annual report is a Form 10-K, or a 20-F or 40-F for a foreign issuer. The quarterly report is a Form 10-Q when the company files one.
- SIC
- 2834 · Pharmaceutical Preparations
- Fiscal year ends
- December 31
- Incorporated
- New York
- Latest annual report
- 10-K filed February 4, 2026
- Latest quarterly report
- 10-Q filed July 30, 2026
- All filings
- Regeneron Pharmaceuticals on EDGAR
More in Health Care
Questions about tracking REGN
Does this page show a live price?
The number you see in the chart is rendered by TradingView’s widget in your browser. OpenStock does not print a quote of its own on this page. A free account adds REGN to a watchlist; email alerts, when that deployment has them, run inside the app.
Where do the filing dates come from?
From the SEC’s EDGAR submissions feed for CIK 872589. The link opens the filing on sec.gov. OpenStock is not affiliated with the SEC.
Track REGN free on OpenStock
Save it to a watchlist, keep the chart open in a tab, and read the filings from one place. OpenStock is not a broker, and nothing here is investment advice.
